CJC-1295 5mg

Description

CJC-1295 5mg

CJC-1295 is a synthetic peptide analog of Growth Hormone-Releasing Hormone (GHRH) that binds to pituitary receptors to stimulate the natural production and release of growth hormone (GH). This process triggers downstream liver synthesis of Insulin-like Growth Factor 1 (IGF-1), which governs tissue recovery, protein synthesis, and metabolic balance.

Key Specifications & Formats

Standard Vial Size: 5 mg (frequently provided as a standalone 5mg vial or a 5mg/5mg blend combined with Ipamorelin).

Function: Promotes native, pulsatile growth hormone output without disrupting internal feedback loops.

Forms: Available with DAC (extended half-life of 6–8 days for constant elevation) and without DAC (short half-life of ~30 minutes for sharp, natural pulses).

Reconstitution and Function FAQs

How is a 5mg vial prepared for use?

Introducing 2 mL of bacteriostatic water into a 5 mg vial creates a concentration of 2.5 mg/mL (or 2,500 mcg/mL), allowing for precise volume measurements on standard insulin syringes.

Home Page

Why is it commonly paired with Ipamorelin?

CJC-1295 stimulates GHRH receptors while Ipamorelin targets ghrelin receptors. Activating these two separate pathways simultaneously yields a synergistic pulse of growth hormone.

When is it typically injected?

Injections are generally administered subcutaneously on an empty stomach right before sleep to naturally complement the body’s primary nocturnal growth hormone surge.